xCures Partners With Massive Bio to Help Advanced Cancer Patients Find the Right Treatment Options

Collaboration between leading AI-enabled oncology corporations helps provide the best arsenal available for advanced cancer patients NEW YORK–(BUSINESS WIRE)–Today, xCures announced their collaboration with Massive Bio Inc. This partnership ensures that advanced cancer patients and their physicians have access to the best treatment options available. Massive Bio is a leader… Read more »

xCures provides early access to xINFORM

Today, xCures enabled early access to xINFORM, an A.I.-powered platform for advanced cancer patients to identify personalized treatment options to discuss with their doctors. xINFORM is available at no charge. Patients participate with their data and receive treatment options that combine the leading thinking in precision medicine, patient preferences, and… Read more »